Long-Term Survival for Platinum-Sensitive Recurrent Ovarian Cancer Patients Treated with Secondary Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy (HIPEC)

被引:0
|
作者
M. Petrillo
P. De Iaco
S. Cianci
M. Perrone
B. Costantini
C. Ronsini
G. Scambia
A. Fagotti
机构
[1] Catholic University of the Sacred Heart,Department of Obstetrics and Gynecology
[2] University of Bologna,Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, S. Orsola Hospital
[3] University of Perugia,Division of Minimally Invasive Gynecological Surgery, St. Maria Hospital
来源
关键词
Peritoneal Cancer Index; Hyperthermic Intraperitoneal Chemotherapy; Memorial Sloan Kettering Cancer Center; Optimal Cytoreduction; Interval Debulking Surgery;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1660 / 1665
页数:5
相关论文
共 50 条
  • [31] Diffuse malignant peritoneal mesothelioma: Long-term survival with complete cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy (HIPEC)
    Baratti, Dario
    Kusamura, Shigeki
    Cabras, Antonello Domenico
    Bertulli, Rossella
    Hutanu, Ionut
    Deraco, Marcello
    EUROPEAN JOURNAL OF CANCER, 2013, 49 (15) : 3140 - 3148
  • [32] Exploring the Survival Determinants in Recurrent Ovarian Cancer: The Role of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
    Geca, Katarzyna
    Litwinski, Jakub
    Ostrowski, Tomasz
    Swietlicka, Izabela
    Polkowski, Wojciech P.
    Skorzewska, Magdalena
    CANCERS, 2024, 16 (11)
  • [33] Effects of CytoReductive surgery plus hyperthermic IntraPEritoneal chemotherapy (HIPEC) versus CytoReductive surgery for ovarian cancer patients: A systematic review and meta-analysis
    Wang, Yizi
    Ren, Fang
    Chen, Peng
    Liu, Shuang
    Song, Zixuan
    Ma, Xiaoxin
    EJSO, 2019, 45 (03): : 301 - 309
  • [34] Evaluation of Extensive Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Epithelial Ovarian Cancer
    Ansaloni, Luca
    Agnoletti, Vanni
    Amadori, Andrea
    Catena, Fausto
    Cavaliere, Davide
    Coccolini, Federico
    De Iaco, Pierandrea
    Di Battista, Monica
    Framarini, Massimo
    Gazzotti, Filippo
    Ghermandi, Claudio
    Kopf, Barbara
    Saponara, Maristella
    Tauceri, Francesca
    Vallicelli, Carlo
    Verdecchia, Giorgio Maria
    Pinna, Antonio Daniele
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2012, 22 (05) : 778 - 785
  • [35] Peritoneal mestastases from rare ovarian cancer treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC)
    Falla-Zuniga, Luis Felipe
    Sardi, Armando
    King, Mary Caitlin
    Lopez-Ramirez, Felipe
    Barakat, Philipp
    Nieroda, Carol
    Diaz-Montes, Teresa
    Gushchin, Vadim
    PLEURA AND PERITONEUM, 2024, 9 (01) : 15 - 22
  • [36] Phase 2 non-randomised trial of secondary cytoreduction and hyperthermic intraperitoneal chemotherapy in recurrent platinum-sensitive ovarian cancer
    Raj, Hemanth
    Keerthi, Marri Sri Santosh
    Palaniappan, Ravisankar
    Prakash, Ujwala
    Dhanushkodi, Manikandan
    Ganesan, Trivadi S.
    ECANCERMEDICALSCIENCE, 2021, 15
  • [37] Association between time to adjuvant chemotherapy and survival in ovarian cancer patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
    Iugai, Sergei
    Sardi, Armando
    Diaz-Montes, Teresa
    King, Mary Caitlin
    Kovalik, Vladislav
    Falla-Zuniga, Luis Felipe
    Uzhegova, Kseniia
    Ledakis, Panayotis
    Nieroda, Carol
    Gushchin, Vadim
    GYNECOLOGIC ONCOLOGY REPORTS, 2025, 58
  • [38] Hyperthermic Intraperitoneal Chemotherapy in Platinum-Sensitive Recurrent Ovarian Cancer: A Randomized Trial on Survival Evaluation (HORSE; MITO-18)
    Fagotti, Anna
    Costantini, Barbara
    Fanfani, Francesco
    Giannarelli, Diana
    De Iaco, Pierandrea
    Chiantera, Vito
    Mandato, Vincenzo
    Giorda, Giorgio
    Aletti, Giovanni
    Greggi, Stefano
    Perrone, A. Myriam
    Salutari, Vanda
    Trozzi, Rita
    Scambia, Giovanni
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (07)
  • [39] Electrolyte and hematological abnormalities in patients with advanced epithelial ovarian cancers treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) or neoadjuvant chemotherapy plus CRS/HIPEC
    Diaz-Montes, T. P.
    Velez-Mejia, C.
    Sittig, M.
    MacDonald, R.
    Gushchin, V.
    Ducie, J. A.
    Ryu, H. S.
    Sardi, A.
    GYNECOLOGIC ONCOLOGY, 2019, 154 : 144 - 144
  • [40] QUALITY OF LIFE IN PLATINUM-SENSITIVE RECURRENT OVARIAN CANCER: CHEMOTHERAPY VERSUS SURGERY PLUS CHEMOTHERAPY
    Luvero, D.
    Plotti, F.
    Terranova, C.
    Montera, R.
    Aloisi, A.
    Hyseni, E.
    Scaletta, G.
    Capriglione, S.
    Miranda, A.
    Angioli, R.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2014, 24 (09) : 89 - 89